logo-loader
LSE:DDDD

4D pharma plc

Receive alerts
Market:
LSE
Market Cap:
£44.29 m
Price
40.45 GBX
Change
0.25%
52 weeks high
131.00
52 weeks low
23.50

In brief

4D are pioneers in harnessing bacteria as a revolutionary new class of medicines – called live biotherapeutics.

Insight Widest with the analysis, Proactive gives perspectives that others don't.

4D pharma: A clinical stage innovator and pioneer of Live Biotherapeutics

Working in the emerging area of the human microbiome, the company has developed candidates in cancer, gastrointestinal and respiratory ailments, and autoimmune disease

3 weeks, 5 days ago